Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.31 Insider Own2.00% Shs Outstand61.22M Perf Week-3.16%
Market Cap731.58M Forward P/E- EPS next Y-0.27 Insider Trans14.39% Shs Float57.07M Perf Month-7.86%
Income-18.60M PEG- EPS next Q-0.11 Inst Own96.00% Short Float7.40% Perf Quarter-10.82%
Sales263.40M P/S2.78 EPS this Y-19.20% Inst Trans-0.12% Short Ratio7.14 Perf Half Y-13.59%
Book/sh3.19 P/B3.75 EPS next Y35.70% ROA-6.00% Target Price16.43 Perf Year10.04%
Cash/sh1.37 P/C8.70 EPS next 5Y20.00% ROE-9.50% 52W Range8.77 - 15.00 Perf YTD19.50%
Dividend- P/FCF- EPS past 5Y24.10% ROI-9.00% 52W High-20.33% Beta0.74
Dividend %- Quick Ratio2.90 Sales past 5Y15.40% Gross Margin38.90% 52W Low36.26% ATR0.51
Employees3200 Current Ratio3.90 Sales Q/Q6.90% Oper. Margin-6.80% RSI (14)39.68 Volatility3.33% 4.36%
OptionableYes Debt/Eq0.01 EPS Q/Q-100.00% Profit Margin-7.10% Rel Volume0.78 Prev Close11.67
ShortableYes LT Debt/Eq0.01 EarningsMay 08 BMO Payout- Avg Volume591.57K Price11.95
Recom2.00 SMA20-5.22% SMA50-9.95% SMA200-4.10% Volume458,659 Change2.40%
03-May-13Reiterated Feltl & Co. Hold $11.50 → $12
01-Mar-13Reiterated Feltl & Co. Hold $13 → $11.50
04-Dec-12Downgrade Northland Securities Outperform → Market Perform
07-Sep-12Initiated Northland Securities Outperform $18
18-Feb-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
03-Dec-10Initiated Jefferies Buy $27
14-Oct-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
15-Sep-10Initiated Feltl & Co. Buy $19
26-Jul-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
06-May-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
08-Jan-10Initiated Rodman & Renshaw Mkt Outperform $11
05-Jun-09Upgrade William Blair Mkt Perform → Outperform
06-Aug-08Reiterated SMH Capital Buy $8 → $7
06-Aug-08Reiterated Canaccord Adams Hold $7 → $4.75
29-Jul-08Initiated SMH Capital Buy $8
14-May-08Reiterated JMP Securities Mkt Outperform $13 → $10
13-May-08Downgrade William Blair Outperform → Mkt Perform
13-May-08Downgrade Canaccord Adams Buy → Hold $12 → $7
13-Feb-08Reiterated SMH Capital Buy $18 → $13
13-Feb-08Reiterated JMP Securities Mkt Outperform $17 → $13
15-Apr-14 08:15AM  NxStage Patient Enjoys Travel and Active Lifestyle PR Newswire -6.67%
08-Apr-14 08:00AM  NxStage® to Report First Quarter 2014 Financial Results PR Newswire
31-Mar-14 08:37AM  NxStage Wins 2014 American Red Cross Northeast Chapter Workplace Hero Award PR Newswire
20-Mar-14 08:00AM  NxStage Establishes First Annual National Home Hemodialysis Day PR Newswire
11-Mar-14 12:53PM  Despite skepticism, market technicals remain bullish at MarketWatch -5.80%
10-Mar-14 01:58PM  Stocks: Insiders Buy at Opko Health and Synageva BioPharma, Sell at EXCO Resources at Minyanville
01:58PM  Stocks: Insiders Buy at Opko Health and Synageva BioPharma, Sell at EXCO Resources
08-Mar-14 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
03-Mar-14 04:16PM  NXSTAGE MEDICAL, INC. Files SEC form 10-K, Annual Report EDGAR Online
27-Feb-14 02:58PM  NxStage Medical's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
02:58PM  NxStage Medical's CEO Discusses Q4 2013 Results - Earnings Call Transcript
08:55AM  NxStage Medical, Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
08:55AM  NxStage Medical, Inc. Discusses Q4 2013 Results (Webcast)
07:45AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:31AM  NxStage Reports Record Fourth Quarter and Full-Year 2013 Financial Results PR Newswire
07:07AM  Q4 2013 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
24-Feb-14 08:00AM  Former NxStage Patient Celebrates Life Milestones PR Newswire
06-Feb-14 04:02PM  NxStage Medical Launches NxStage Plus One at 2014 Annual Dialysis Conference PR Newswire
21-Jan-14 08:24AM  NxStage® to Report Fourth Quarter and Full Year 2013 Financial Results PR Newswire
08:24AM  NxStage® to Report Fourth Quarter and Full Year 2013 Financial Results
15-Jan-14 11:33PM  NxStage Medical CEO Presents at JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
11:33PM  NxStage Medical CEO Presents at JPMorgan Healthcare Conference (Transcript)
14-Jan-14 02:20PM  3 Stocks Spiking on Big Volume at TheStreet +10.52%
02:20PM  3 Stocks Spiking on Big Volume
13-Jan-14 04:14PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
04:14PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:05PM  NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013 PR Newswire
04:05PM  NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013
06:47AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
06:47AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
08-Jan-14 12:33PM  NxStage Gaining Ground On Growing Adoption Of Home Hemodialysis at Seeking Alpha +5.84%
12:33PM  NxStage Gaining Ground On Growing Adoption Of Home Hemodialysis
06-Jan-14 05:09PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events EDGAR Online
05:09PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
31-Dec-13 08:00AM  NxStage to Present at the 32nd Annual J.P. Morgan Healthcare Conference PR Newswire
08:00AM  NxStage to Present at the 32nd Annual J.P. Morgan Healthcare Conference
05-Dec-13 11:02AM  Fundamentally And Technically, Fresenius Wins Big Over DaVita at Seeking Alpha
11:02AM  Fundamentally And Technically, Fresenius Wins Big Over DaVita
26-Nov-13 10:23AM  Is It Time to Buy These 4 Dialysis Stocks? at Motley Fool
10:23AM  Is It Time to Buy These 4 Dialysis Stocks?
25-Nov-13 10:24AM  Moving Average Crossover: Great News for NxStage Medical, Inc. (NXTM)? Zacks
10:24AM  Moving Average Crossover: Great News for NxStage Medical, Inc. (NXTM)?
14-Nov-13 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
01:04PM  NXSTAGE MEDICAL, INC. Financials
09-Nov-13 09:09AM  3 Horrendous Health-Care Stocks This Week at Motley Fool
09:09AM  3 Horrendous Health-Care Stocks This Week
08-Nov-13 06:02PM  Nasdaq stocks posting largest percentage decreases AP
04:04PM  Nasdaq stocks posting largest percentage decreases AP
12:17AM  NxStage Medical's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
12:17AM  NxStage Medical's CEO Discusses Q3 2013 Results - Earnings Call Transcript
07-Nov-13 06:02PM  Nasdaq stocks posting largest percentage decreases AP -16.01%
02:43PM  Why NxStage Medical Inc. Shares Slumped at Motley Fool
02:43PM  Why NxStage Medical Inc. Shares Slumped
01:47PM  Nasdaq stocks posting largest percentage decreases AP
09:00AM  NxStage Medical, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:55AM  NxStage Medical, Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
07:56AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:42AM  InPlay: Nxstage Medical misses by $0.02, reports revs in-line; guides Q4 EPS below consensus, revs below consensus Briefing.com
07:35AM  NxStage Medical, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:31AM  NxStage Reports Third Quarter 2013 Financial Results PR Newswire
07:08AM  Q3 2013 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
06-Nov-13 04:43PM  NxStage Medical Introduces New Products at 2013 American Society of Nephrology Meeting PR Newswire -7.27%
05-Nov-13 04:30PM  NxStage Announces Fourth Quarter 2013 Investor Conference Schedule PR Newswire
24-Oct-13 04:58PM  Hedge Funds Like These 6 Medical Suppliers During Obamacare Rollout at TheStreet
23-Oct-13 09:28AM  Nxstage Medical President Sells 75K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet
17-Oct-13 11:08AM  NxStage® Launches New Home Hemodialysis Educational Resource PR Newswire
09-Oct-13 08:00AM  NxStage® to Report Third Quarter Fiscal 2013 Financial Results PR Newswire
07-Oct-13 09:11AM  Introducing NxStage Kidney Care: Expanding Access To Therapy Options And Empowering Patients To Feel More In Control Of Their Lives PR Newswire
23-Sep-13 08:00AM  NxStage Introduces Web-Based Dosing Calculator PR Newswire
17-Sep-13 02:36PM  Why Are Investors Thrilled About This Company's Iron Treatment? at Motley Fool
12-Sep-13 08:00AM  NxStage® System One Patients to Participate in 220 Mile Bike Ride to Raise Awareness of Kidney Disease PR Newswire
04-Sep-13 05:00PM  NxStage Urges CMS to Fix Training Reimbursement to Provide Medicare Patients Greater Access to Life-Changing Home Hemodialysis Therapies PR Newswire
08-Aug-13 06:05AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
02-Aug-13 11:45AM  Wall Street Transcript interview with Chris Cooley, Managing Director at Stephens Inc.: Medical Device Manufacturers Focus on International Markets, Clinical Benefits and Cost Savings Wall Street Transcript
01-Aug-13 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
31-Jul-13 08:00AM  NxStage Announces Third Quarter 2013 Investor Conference Schedule PR Newswire
28-Jul-13 03:19PM  5 Rising Stocks to Watch Now at Wall St. Cheat Sheet
25-Jul-13 05:37PM  Nxstage Medical Earnings: Heres Why Investors are Selling Shares Now at Wall St. Cheat Sheet
05:21PM  Nxstage Medical Beats on Both Top and Bottom Lines at Motley Fool
03:04PM  NxStage Medical, Inc. (NXTM) CEO Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha
07:24AM  NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2013 PR Newswire
07:07AM  Q2 2013 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
12:48AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
24-Jul-13 09:58AM  Battelle Team Wins DARPA Contract to Build Medical Device to Treat Sepsis Marketwired
22-Jul-13 08:00AM  NxStage Congratulates Home Dialyzors United for Securing Policies through the US Department of Transportation to Improve the Air Travel Experience for Home Dialyzors PR Newswire
01:34AM  Can Nxstage Medical Meet These Numbers? at Motley Fool
16-Jul-13 04:15PM  Forbes Earnings Preview: Baxter International (BAX) at Forbes
01-Jul-13 08:00AM  NxStage(R) to Report Second Quarter Fiscal 2013 Financial Results PR Newswire
29-Jun-13 01:02AM  Here's Why Nxstage Medical's Earnings Are Worse Than They Look at Motley Fool
26-Jun-13 05:40PM  NxStage Medical Appoints New CFO at Motley Fool
04:04PM  CFO Moves: NxStage Medical, Tessera Technologies, Las Vegas Sands at The Wall Street Journal
10:07AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08:07AM  InPlay: Nxstage Medical announces that Matthew W. Towse has been appointed Senior Vice President and Chief Financial Officer Briefing.com
08:00AM  NxStage Names New Chief Financial Officer and Appoints Leader of NxStage Centers of Excellence PR Newswire
21-Jun-13 08:00AM  Jay Shreiner Joins NxStage Board of Directors PR Newswire
01:18AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
18-Jun-13 01:04AM  A Hidden Reason Nxstage Medical's Future Looks Bright at Motley Fool
24-May-13 09:11AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
21-May-13 05:10PM  InPlay: Nxstage Medical announces new agreements with DaVita Briefing.com
05:09PM  NxStage Announces New Agreements with DaVita PR Newswire
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product is the NxStage System One, a portable hemodialysis system used for the treatment of acute and chronic kidney failure, and fluid overload. The company operates in two segments, System One and In-Center. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment. This segment also sells extracorporeal disposable products, which are primarily used for in-center dialysis treatments for patients with end-stage renal disease (ESRD) in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers; and needles for apheresis. NxStage Medical, Inc. markets its products through direct sales force and distributors to hospitals and dialysis centers in the United States and internationally. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Robert S.President, Kidney CareMar 09Option Exercise0.003,056048,665Mar 11 09:29 PM
Hershberger KevinChief Accounting OfficerMar 09Option Exercise0.001,146029,367Mar 11 09:14 PM
Turk Joseph E JrPresidentMar 09Option Exercise0.003,0560132,974Mar 11 09:05 PM
Swan Winifred LSVP and General CounselMar 09Option Exercise0.003,056027,727Mar 11 08:57 PM
FUNARI ROBERT GDirectorMar 06Buy14.7210,150149,40810,150Mar 07 04:48 PM
MOORE CRAIG WDirectorMar 05Option Exercise3.3814,00047,32098,750Mar 07 04:46 PM
Swan Winifred LSVP and General CounselMar 04Option Exercise0.003,675026,064Mar 06 07:11 PM
Turk Joseph E JrPresidentMar 04Option Exercise0.003,6750131,311Mar 06 07:10 PM
Hershberger KevinChief Accounting OfficerMar 04Option Exercise0.001,378028,744Mar 06 07:09 PM
Burbank Jeffrey HCEOMar 04Option Exercise0.0010,1070644,454Mar 06 07:08 PM
Brown Robert S.President, Kidney CareMar 04Option Exercise0.003,675047,002Mar 06 07:08 PM
Giannini Daniel ADirectorJan 02Option Exercise3.3814,00047,32067,540Jan 03 05:05 PM
REID PERPERDirectorDec 11Option Exercise3.3814,00047,320116,911Dec 13 06:48 AM
Turk Joseph E JrPresidentDec 10Option Exercise5.7417,422100,006127,636Dec 11 05:26 PM
Swan Winifred LSVP and General CounselDec 10Option Exercise5.472,99716,39422,389Dec 11 05:27 PM
Brown Robert S.President, Kidney CareDec 10Option Exercise3.1510,80534,04943,327Dec 12 05:02 PM
Burbank Jeffrey HCEODec 10Option Exercise5.4720,735113,420634,347Dec 12 05:00 PM
Burbank Jeffrey HCEONov 19Option Exercise5.4723,868130,558613,612Nov 20 05:27 PM
Brown Robert S.President, Kidney CareOct 21Option Exercise8.9275,309671,756107,831Oct 22 05:28 PM
Brown Robert S.President, Kidney CareOct 21Sale14.0075,3091,054,32632,522Oct 22 05:28 PM
Brown Robert S.President, Kidney CareOct 18Option Exercise8.9264,791577,93697,313Oct 22 05:28 PM
Brown Robert S.President, Kidney CareOct 18Sale14.0064,791907,07432,522Oct 22 05:28 PM
Snell Todd MSVP, QA, Reg.&Clinical AffairsSep 10Sale12.624275,3896,049Sep 12 05:15 PM
Shea ThomasSVP Manufacturing OperationsSep 09Sale12.301,00012,30010,899Sep 10 09:00 AM
Shea ThomasSVP Manufacturing OperationsAug 12Sale12.931,17215,15411,899Aug 14 05:39 PM
Shea ThomasSVP Manufacturing OperationsJul 08Option Exercise4.325,00021,60020,071Jul 10 04:11 PM
Shea ThomasSVP Manufacturing OperationsJul 08Sale14.347,000100,38013,071Jul 10 04:11 PM
Shea ThomasSVP Manufacturing OperationsJun 10Option Exercise4.325,00021,60025,071Jun 10 07:05 PM
Snell Todd MSVP, QA, Reg.&Clinical AffairsJun 10Sale13.654275,8296,476Jun 10 07:04 PM
Shea ThomasSVP Manufacturing OperationsJun 10Sale13.735,00068,62915,071Jun 12 04:36 PM
Shea ThomasSVP Manufacturing OperationsJun 10Sale13.735,00068,62920,071Jun 10 07:05 PM
Shea ThomasSVP Manufacturing OperationsMay 13Option Exercise2.115,72412,07835,795May 14 04:27 PM
Shea ThomasSVP Manufacturing OperationsMay 13Sale12.6715,724199,15120,071May 14 04:27 PM